Insmed Announces PAH Presentations at the American Thoracic Society 2015 Meeting
Insmed Incorporated, a biopharmaceutical company dedicated to improving the lives of patients battling rare lung diseases by developing orphan treatments recently announced that during the 2015 Annual Internation Conference of the American Thoracic Society (ATS) it will present three ARIKAYCEâ„¢ abstracts and three INS1009 abstracts. The conference will place…